Question 1

What is Shanghai Henlius Biotech?

Accepted Answer

Shanghai Henlius Biotech is a Company.

Question 2

How often does Shanghai Henlius Biotech appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was Shanghai Henlius Biotech first tracked by Ergen?

Accepted Answer

First tracked on Apr 29, 2026.

Question 4

When was Shanghai Henlius Biotech last mentioned in news?

Accepted Answer

Last active on Aug 06, 2026.

Question 5

What is Shanghai Henlius Biotech's current news sentiment?

Accepted Answer

Aggregate sentiment score: 30 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Shanghai Henlius Biotech in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Shanghai Henlius Biotech?

Accepted Answer

POHERDY Biosimilar Approved in Europe (Apr 29, 2026, 6 articles).

Question 8

How did the "POHERDY Biosimilar Approved in Europe" event impact Shanghai Henlius Biotech?

Accepted Answer

Shanghai Henlius Biotech, in collaboration with Organon, received International — European Commission marketing authorization for POHERDY, its biosimilar to PERJETA, expanding its global portfolio and market access.

Question 9

How did the "Chinese drugmakers face talent shortage" event impact Shanghai Henlius Biotech?

Accepted Answer

Established in-house clinical and regulatory teams in US, Europe, Japan, and Australia to independently operate trials.

Question 10

How did the "Fosun International Wins ESG and CSR Awards" event impact Shanghai Henlius Biotech?

Accepted Answer

AI-powered drug design platform improved binding affinity, accelerating drug development.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.